Efficacy of a dermocosmetic containing neuroserine, sphingobioma and niacinamide in atopic dermatitis patients – Achieving rapid symptom relief, improvement of disease severity and quality of life over time

D. Luschkova, PA. Enders, R. Rohayem, C. Gülzow, G.Hammel, D.Kerob, M. Niore, M. Reiger, C. Traidl-Hoffmann

INTRODUCTION

Background: Atopic Dermatitis (AD) is a chronic inflammatory skin disease associated with dysfunctional integrity of epidermal barrier, which frequently results in skin dryness, itching, burning sensations and inflammatory lesions. Maintaining and stabilizing the skin barrier is essential for preventing and treating AD. Everyday emollient therapy is the basis of AD treatment and helps to restore epidermal barrier functions.
Objectives: The purpose of this clinical study was to evaluate the effects of a face skin care cream (DC) on skin barrier function, clinical symptoms, skin appearance, and quality of life in patients with AD.